Serum transforming growth factor-β1 and epidermal growth factor in biliary atresia

European Journal of Pediatric Surgery

Volumn 18, Issue 6, 2008, Pages 415-418

  Vejchapipat, Paisarn ^a   Theamboonlers, A ^b   Poomsawat, S ^c   Chittmittrapap, S ^a   Poovorawan, Y ^b  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b THAMMASAT UNIVERSITY   (Thailand)

^c MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Biliary atresia; EGF; TGF

Indexed keywords

EPIDERMAL GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; BILE DUCT ATRESIA; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SCHOOL CHILD;

BILIARY ATRESIA; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHILD; DISEASE PROGRESSION; EPIDERMAL GROWTH FACTOR; FEMALE; HUMANS; LIVER CIRRHOSIS; MALE; POSTOPERATIVE PERIOD; PROGNOSIS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 58149288001     PISSN: 09397248     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1038950     Document Type: Article

References (27)

1. Berlanga J, Caballero ME, Ramirez D et al. Epidermal growth factor protects against carbon tetrachloride-induced hepatic injury. Clin Sci (Lond) 1998; 94: 219-223
2. Bissig KD, Marti U, Solioz M et al. Epidermal growth factor is decreased in liver of rats with biliary cirrhosis but does not act as paracrine 'growth factor immediately after hepatectomy. J Hepatol 2000; 33: 275-281
3. Deneme MA, Ok E, Akcan A, Akyildiz H, Soyuer I, Muhtaroglu S. Single dose of anti-transforming growth factor-beta1 monoclonal antibody enhances liver regeneration after partial hepatectomy in biliary-obstructed rats. J Surg Res 2006; 136: 280-287
4. Hashimoto M, Kothary PC, Eckhauser FE, Raper SE. Treatment of cirrhotic rats with epidermal growth factor and insulin accelerates liver DNA synthesis after partial hepatectomy. J Gastroenterol Hepatol 1998; 13: 1259-1265
5. Honsawek S, Chongsrisawat V, Vejchapipat P, Thawornsuk N, Tangkijvanich P, Poovorawan Y. Serum interleukin-8 in children with biliary atresia: relationship with disease stage and biochemical parameters. Pediatr Surg Int 2005; 21: 73-77
6. Kayano K, Okita K. Does IL-6 regulate liver fibrosis/cirrhosis directly and indirectly? J Gastroenterol 2000; 35: 250-251
7. Kelly DA, Davenport M. Current management of biliary atresia. Arch Dis Child 2007; 92: 1132-1135
8. Kirmaz C, Terzioglu E, Topalak O et al. Serum transforming growth factor-beta1(TGF-beta1) in patients with cirrhosis, chronic hepatitis B and chronic hepatitis C [corrected]. Eur Cytokine Netw 2004; 15: 112-116
9. Kiyama S, Yamada T, Iwata H et al. Reduction of fibrosis in a rat model of non-alcoholic steatohepatitis cirrhosis by human HGF gene transfection using electroporation. J Gastroenterol Hepatol 2008; 23: e471-e576 (Epub 2007 Aug 30)
10. Kobayashi H, Horikoshi K, Long L, Yamataka A, Lane GJ, Miyano T. Serum concentration of adhesion molecules in postoperative biliary atresia patients: relationship to disease activity and cirrhosis. J Pediatr Surg 2001; 36: 1297-1301
11. Kobayashi H, Hayashi N, Hayashi K, Yamataka A, Lane GJ, Miyano T. Connective tissue growth factor and progressive fibrosis in biliary atresia. Pediatr Surg Int 2005; 21: 12-16
12. Kobayashi H, Horikoshi K, Yamataka A et al. Are stable postoperative biliary atresia patients really stable? Pediatr Surg Int 2001; 17: 104-107
13. Komuves LG, Feren A, Jones AL, Fodor E. Expression of epidermal growth factor and its receptor in cirrhotic liver disease. J Histochem Cytochem 2000; 48: 821-830
14. Liu C, Chiu J-H, Chin T et al. Expression of Fas ligand on bile ductule epithelium in biliary atresia - a poor prognostic factor. J Pediatr Surg 2000; 35: 1591-1596
15. Malizia G, Brunt EM, Peters MG, Rizzo A, Broekelmann TJ, McDonald JA. Growth factor and procollagen type I gene expression in human liver disease. Gastroenterology 1995; 108: 145-156
16. Mitsue S, Hamanoue M, Tanabe G et al. Expression of HGF and TGF-beta 1 mRNA after partial hepatectomy in rats with liver cirrhosis. Surg Today 1995; 25:237-243
17. Moreira RK. Hepatic stellate cells and liver fibrosis. Arch Pathol Lab Med 2007; 131:1728-1734
18. Napoli J, Prentice D, Niinami C, Bishop GA, Desmond P, McCaughan GW. Sequential increases in the intrahepatic expression of epidermal growth factor, basic fibroblast growth factor, and transforming growth factor beta in a bile duct ligated rat model of cirrhosis. Hepatology 1997; 26: 624-633
19. Ohi R. Biliary atresia. A surgical perspective. Clin Liver Dis 2000; 4: 779-804
20. Ohi R. Surgery for biliary atresia. Liver 2001; 21: 175-182
21. Ramm GA, Nair VG, Bridle KR, Shepherd RW, Crawford DH. Contribution of hepatic parenchymal and nonparenchymal cells to hepatic fibrogenesis in biliary atresia. Am J Pathol 1998; 153: 527-535
22. Skov Olsen P, Boesby S, Kirkegaard P et al. Influence of epidermal growth factor on liver regeneration after partial hepatectomy in rats. Hepatology 1988; 8: 992-996
23. Uchida K, Inoue M, Otake K et al. The significance of serum hepatocyte growth factor levels in planning follow-up of postoperative jaundice-free patients with biliary atresia. J Pediatr Surg 2006; 41: 1657-1662
24. Ueno T, Nakamura T, Torimura T, Sata M. Angiogenic cell therapy for hepatic fibrosis. Med Mol Morphol 2006; 39: 16-21
25. Vejchapipat P, Theamboonlers A, Chaokhonchai R, Chongsrisawat V, Chittmittrapap S, Poovorawan Y. Serum hepatocyte growth factor and clinical outcome in biliary atresia. J Pediatr Surg 2004; 39: 1045-1049
26. Yang C, Zeisberg M, Mosterman B et al. Liver fibrosis: insights into migration of hepatic stellate cells in response to extracellular matrix and growth factors. Gastroenterology 2003; 124: 147-159
27. Yoshida S, Nio M, Hayashi Y, Ohi R, Kawamura I, Goto T. Serum insulin-like growth factor-I in biliary atresia. J Pediatr Surg 2003; 38: 211-215